Effect of chronic hyperoxic exposure on duroquinone reduction in adult rat lungs.
NAD(P)H:quinone oxidoreductase 1 (NQO1) plays a dominant role in the reduction of the quinone compound 2,3,5,6-tetramethyl-1,4-benzoquinone (duroquinone, DQ) to durohydroquinone (DQH2) on passage through the rat lung. Exposure of adult rats to 85% O2 for > or =7 days stimulates adaptation to the otherwise lethal effects of >95% O2. The objective of this study was to examine whether exposure of adult rats to hyperoxia affected lung NQO1 activity as measured by the rate of DQ reduction on passage through the lung. We measured DQH2 appearance in the venous effluent during DQ infusion at different concentrations into the pulmonary artery of isolated perfused lungs from rats exposed to room air or to 85% O2. We also evaluated the effect of hyperoxia on vascular transit time distribution and measured NQO1 activity and protein in lung homogenate. The results demonstrate that exposure to 85% O2 for 21 days increases lung capacity to reduce DQ to DQH2 and that NQO1 is the dominant DQ reductase in normoxic and hyperoxic lungs. Kinetic analysis revealed that 21-day hyperoxia exposure increased the maximum rate of pulmonary DQ reduction, Vmax, and the apparent Michaelis-Menten constant for DQ reduction, Kma. The increase in Vmax suggests a hyperoxia-induced increase in NQO1 activity of lung cells accessible to DQ from the vascular region, consistent qualitatively but not quantitatively with an increase in lung homogenate NQO1 activity in 21-day hyperoxic lungs. The increase in Kma could be accounted for by approximately 40% increase in vascular transit time heterogeneity in 21-day hyperoxic lungs.
Department of Biomedical Engineering, Marquette University, Milwaukee, Wisconsin, USA. audis@mu.edu
Said H
SH
Audi
Robert D
RD
Bongard
Gary S
GS
Krenz
David A
DA
Rickaby
Steven T
ST
Haworth
Jessica
J
Eisenhauer
David L
DL
Roerig
Marilyn P
MP
Merker
D000818:Animals; D016227:Benzoquinones / Q000378:metabolism*; D002908:Chronic Disease; D018496:Hyperoxia / Q000378:metabolism*; D066298:In Vitro Techniques; D007700:Kinetics; D008168:Lung / Q000378:metabolism*; D016660:NAD(P)H Dehydrogenase (Quinone) / Q000378:metabolism; D010084:Oxidation-Reduction; D010477:Perfusion; D011652:Pulmonary Circulation; D051381:Rats; D017207:Rats, Sprague-Dawley
D016227:Benzoquinones; D016660:NAD(P)H Dehydrogenase (Quinone); C447479:NQO1 protein, human; C034257:duroquinone